Andrew William Trafford

Andrew William Trafford

Auto-generated profile, based on publicly available information

Andrew William Trafford

University of Manchester

Research Focus & Metrics

Academic Career Length

31Years (1996-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2012 in Circulation
Verified
Journal Article
Closed access
PDF file
NVNiels Voigt
Niels Voigt
NLNa Li
Na Li
QWQiongling Wang
Qiongling Wang
WWWei Wang
Wei Wang
ATAndrew W. Trafford
Andrew W. Trafford
DDDobromir Dobrev
Dobromir Dobrev
Background—: Delayed afterdepolarizations (DADs) carried by Na + -Ca 2+ -exchange current (I NCX ) in response to sarcoplasmic reticulum (SR) Ca 2+ leak can promote atrial fibrillation (AF). The mechanisms leading to delayed afterdepolarizations in AF patients have not been defined. Methods and Results—: Protein levels (Western blot), membrane currents and action potentials (patch clamp), and [Ca 2+ ] i (Fluo-3) were measured in right atrial samples from 76 sinus rhythm (control) and 72 chronic AF (cAF) patients. Diastolic [Ca 2+ ] i and SR Ca 2+ content (integrated I NCX during caffeine-induced Ca 2+ transient) were unchanged, whereas diastolic SR Ca 2+ leak, estimated by blocking ryanodine receptors (RyR2) with tetracaine, was ≈50% higher in cAF versus control. Single-channel recordings from atrial RyR2 reconstituted into lipid bilayers revealed enhanced open probability in cAF samples, providing a molecular basis for increased SR Ca 2+ leak. Calmodulin expression (60%), Ca 2+ /calmodulin-dependent protein kinase-II (CaMKII) autophosphorylation at Thr287 (87%), and RyR2 phosphorylation at Ser2808 (protein kinase A/CaMKII site, 236%) and Ser2814 (CaMKII site, 77%) were increased in cAF. The selective CaMKII blocker KN-93 decreased SR Ca 2+ leak, the frequency of spontaneous Ca 2+ release events, and RyR2 open probability in cAF, whereas protein kinase A inhibition with H-89 was ineffective. Knock-in mice with constitutively phosphorylated RyR2 at Ser2814 showed a higher incidence of Ca 2+ sparks and increased susceptibility to pacing-induced AF compared with controls. The relationship between [Ca 2+ ] i and I NCX density revealed I NCX upregulation in cAF. Spontaneous Ca 2+ release events accompanied by inward I NCX currents and delayed afterdepolarizations/triggered activity occurred more often and the sensitivity of resting membrane voltage to elevated [Ca 2+ ] i (diastolic [Ca 2+ ] i –voltage coupling gain) was higher in cAF compared with control. Conclusions—: Enhanced SR Ca 2+ leak through CaMKII-hyperphosphorylated RyR2, in combination with larger I NCX for a given SR Ca 2+ release and increased diastolic [Ca 2+ ] i -voltage coupling gain, causes AF-promoting atrial delayed afterdepolarizations/triggered activity in cAF patients.

10 February 2011 in British Journal of Pharmacology
Verified
Journal Article
Open access
PDF file
HLHg Laverty
Hg Laverty
CBC Benson
C Benson
ECElizabeth J Cartwright
Elizabeth J Cartwright
MCMj Cross
Mj Cross
CGC Garland
C Garland
JVJp Valentin
Jp Valentin
Given that cardiovascular safety liabilities remain a major cause of drug attrition during preclinical and clinical development, adverse drug reactions, and post‐approval withdrawal of medicines, the Medical Research Council Centre for Drug Safety Science hosted a workshop to discuss current challenges in determining, understanding and addressing ‘Cardiovascular Toxicity of Medicines’. This article summarizes the key discussions from the workshop that aimed to address three major questions: (i) what are the key cardiovascular safety liabilities in drug discovery, drug development and clinical practice? (ii) how good are preclinical and clinical strategies for detecting cardiovascular liabilities? and (iii) do we have a mechanistic understanding of these liabilities? It was concluded that in order to understand, address and ultimately reduce cardiovascular safety liabilities of new therapeutic agents there is an urgent need to: Fully characterize the incidence, prevalence and impact of drug‐induced cardiovascular issues at all stages of the drug development process. Ascertain the predictive value of existing non‐clinical models and assays towards the clinical outcome. Understand the mechanistic basis of cardiovascular liabilities; by addressing areas where it is currently not possible to predict clinical outcome based on preclinical safety data. Provide scientists in all disciplines with additional skills to enable them to better integrate preclinical and clinical data and to better understand the biological and clinical significance of observed changes. Develop more appropriate, highly relevant and predictive tools and assays to identify and wherever feasible to eliminate cardiovascular safety liabilities from molecules and wherever appropriate to develop clinically relevant and reliable safety biomarkers.

13 September 2007 in Cardiovascular Research
Verified
Journal Article
Open access
PDF file
LVLuigi A. Venetucci
Luigi A. Venetucci
ATAndrew W. Trafford
Andrew W. Trafford
SOStephen C. O'Neill
Stephen C. O'Neill
DEDavid A. Eisner
David A. Eisner
There is much evidence showing that some lethal ventricular arrhythmias arise from waves of Ca2+ release from the sarcoplasmic reticulum (SR) that propagate along cardiac cells. The purpose of this review is to discuss the mechanism of production of these waves and how they depend on the properties of the SR Ca2+ release channel or ryanodine receptor (RyR). The best-known method of producing Ca2+ waves is by increasing the Ca2+ content of the cell by either increasing Ca2+ influx or decreasing efflux. Once SR Ca2+ content reaches a threshold level a Ca2+ wave is produced. Altering the properties of the RyR affects the threshold level of Ca2+ required to produce a wave. Patients with a mutation in the RyR suffer from catecholaminergic polymorphic ventricular tachycardia, and this may be due to a decrease in the SR Ca2+ threshold for wave production. Heart failure has also been suggested to result in Ca2+ waves due to a leak of Ca2+ through the RyR. We review the finding that these changes in RyR function will only result in Ca2+ waves in the steady state if some other mechanism maintains the SR Ca2+ content. The review concludes with a description of potential mechanisms for treating arrhythmias produced by Ca2+ waves.

8 December 2000 in Circulation Research
Verified
Journal Article
Closed access
PDF file
DED. A. Eisner
D. A. Eisner
HCH. S. Choi
H. S. Choi
MDM. E. DíaZ
M. E. DíaZ
SOS. C. O’nEill
S. C. O’nEill
ATA. W. Trafford
A. W. Trafford
—The control of intracellular calcium is central to regulation of contractile force in cardiac muscle. This review illustrates how analysis of the control of calcium requires an integrated approach in which several systems are considered. Thus, the calcium content of the sarcoplasmic reticulum (SR) is a major determinant of the amount of Ca 2+ released from the SR and the amplitude of the Ca 2+ transient. The amplitude of the transient, in turn, controls Ca 2+ fluxes across the sarcolemma and thence SR content. This control of SR content influences the response to maneuvers that modify, for example, the properties of the SR Ca 2+ release channel or ryanodine receptor. Specifically, modulation of the open probability of the ryanodine receptor produces only transient effects on the Ca 2+ transient as a result of changes of SR content. These interactions between various Ca 2+ fluxes are modified by the Ca 2+ buffering properties of the cell. Finally, we predict that, under some conditions, the above interactions can result in instability (such as alternans) rather than ordered control of contractility.

5 January 2007 in Circulation Research
Verified
Journal Article
Closed access
PDF file
LVLuigi A. Venetucci
Luigi A. Venetucci
ATAndrew W. Trafford
Andrew W. Trafford
DEDavid A. Eisner
David A. Eisner
Diastolic waves of Ca 2+ release have been shown to activate delayed afterdepolarizations as well as some cardiac arrhythmias. The aim of this study was to investigate whether increasing ryanodine receptor open probability alone or in the presence of β-adrenergic stimulation produces diastolic Ca release from the sarcoplasmic reticulum (SR). When voltage-clamped rat ventricular myocytes were exposed to caffeine (0.5 to 1.0 mmol), diastolic Ca 2+ release was seen to accompany the first few stimuli but was never observed in the steady state. We attribute the initial phase of diastolic Ca 2+ release to a decrease in the threshold SR Ca 2+ content required to activate Ca 2+ waves and its subsequent disappearance to a decrease of SR content below this threshold. Application of isoproterenol (1 μmol/L) increased the amplitude of the systolic Ca 2+ transient and also the SR Ca 2+ content but did not usually produce diastolic Ca 2+ release. Subsequent addition of caffeine, however, resulted in diastolic Ca 2+ release. We estimated the time course of recovery of SR Ca 2+ content following recovery from emptying with a high (10 mmol/L) concentration of caffeine. Diastolic Ca 2+ release recommenced only when SR content had increased back to its final level. We conclude that increasing ryanodine receptor open probability alone does not produce arrhythmogenic diastolic Ca 2+ release because of the accompanying decrease of SR Ca 2+ content. β-Adrenergic stimulation increases SR content and thereby allows the increased ryanodine receptor open probability to produce diastolic Ca 2+ release. The implications of these results for arrhythmias associated with abnormal ryanodine receptors are discussed.

1 April 2009 in Journal of Molecular and Cellular Cardiology
Verified
Journal Article
Closed access
AWA.P. Walden
A.P. Walden
KDK.M. Dibb
K.M. Dibb
ATA.W. Trafford
A.W. Trafford